Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterActive in the last 2 years

Saswati Karmakar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0315-5924; OpenAlex author ID A5066886590; NIH RePORTER profile ID 12480817. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
2
Labs led
0
Collaborators
32
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 1 paper, 1 grant · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 grant

Papers 8

  1. Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. Co-author DOI 10.1038/s41388-021-02047-2↗
  2. SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1128/mcb.00135-21↗
  3. Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. Co-author DOI 10.1038/s41416-020-0772-3↗
  4. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A a… Co-author DOI 10.1053/j.gastro.2020.07.053↗
  5. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention. Co-author DOI 10.1016/j.semcancer.2017.11.020↗
  6. Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1. Co-author DOI 10.1053/j.gastro.2018.05.041↗
  7. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells. Co-author DOI 10.1186/s12885-018-5074-2↗
  8. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.6580↗

Grants 2

  1. Pancreatic cancer stem cells: PD2-mediated novel mechanistic link and metabolomic alterations K00CA234962↗
  2. Pancreatic cancer stem cells: PD2-mediated novel mechanistic link and metabolomic alterations F99CA234962↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Moorthy Palanimuthu Ponnusamy · 8 shared papers, 2016–2022 · strength 0.78
  2. Surinder K. Batra · 7 shared papers, 2016–2022 · strength 0.67
  3. Satyanarayana Rachagani · 7 shared papers, 2016–2022 · strength 0.66
  4. Rama Krishna Nimmakayala · 6 shared papers, 2018–2022 · strength 0.64
  5. Seema Chugh · 4 shared papers, 2018–2022 · strength 0.40
  6. Sanchita Rauth · 4 shared papers, 2018–2021 · strength 0.36
  7. Frank Leon · 3 shared papers, 2020–2022 · strength 0.35
  8. Palanisamy Nallasamy · 3 shared papers, 2020–2022 · strength 0.35
  9. Parthasarathy Seshacharyulu · 3 shared papers, 2018–2022 · strength 0.32
  10. Rohitesh Gupta · 2 shared papers, 2020 · strength 0.20
  11. Garima Kaushik · 2 shared papers, 2018–2019 · strength 0.20
  12. Srikanth Barkeer · 2 shared papers, 2018–2020 · strength 0.18
  13. Sakthivel Muniyan · 2 shared papers, 2016–2021 · strength 0.17
  14. Jesse L. Cox · 1 shared paper, 2022 · strength 0.14
  15. Kavita B. Mallya · 1 shared paper, 2022 · strength 0.14
  16. Lynette M. Smith · 2 shared papers, 2016–2018 · strength 0.12
  17. Imayavaramban Lakshmanan · 2 shared papers, 2016–2018 · strength 0.12
  18. Subodh M. Lele · 2 shared papers, 2016–2018 · strength 0.12
  19. Michel M. Ouellette · 2 shared papers, 2016–2018 · strength 0.12
  20. Koelina Ganguly · 1 shared paper, 2021 · strength 0.11
  21. Sushil Kumar · 1 shared paper, 2021 · strength 0.11
  22. Chi H. Lin · 1 shared paper, 2021 · strength 0.11
  23. Ashu Shah · 1 shared paper, 2021 · strength 0.11
  24. Rakesh Bhatia · 1 shared paper, 2021 · strength 0.11
  25. Dipakkumar R. Prajapati · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.